Pro-B-type natriuretic peptide strongly predicts major cardiovascular events and cardiovascular mortality in coronary artery disease patients with NAFLD as well as in those without NAFLD
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
0012o00003HdGn8AAF (VIVIT), Feldkirch (Austria)
8 More presentations in this session
Mrs L. Cosenso-Martin (Sao Jose do Rio Preto, BR)
Associate Professor M. Chlabicz (Bialystok, PL)
Professor R. Gupta (Jaipur, IN)
Professor H. Rosjo (Nordbyhagen, NO)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
